Orality
Model
81%
Oral-dominant (speeches, podcasts, storytelling)
Speaker Breakdown
HostTracy Alloway(1,554 words)
M:94%
HostJoe Weisenthal(1,466 words)
M:29%
GuestJamey Mock(5,849 words)
M:92%
Oral Indicators
Agonistic32%
massive, very, obviously
Engagement87%
you, our, your
Memory Aids100%
listen, well, right
Repetition100%
know (86x), what (68x), like (64x)
Parallelism100%
And I'm Joe Weisenthal...., And as you're right, it kind o..., But I guess I only partly know...
Sound Patterns74%
71 question(s), alliteration: "markets move", alliteration: "barclays brief"
Formulaic Phrases6%
at the end of the day, you know what, i mean
Literate Indicators
Hedging7%
could, maybe, relatively
Passive Voice5%
are excited, is often, been approved
Abstract Nouns17%
investment, information, volatility
Subordination7%
because, although, since
Sentence Length45%
Avg: 16.2 words/sentence
Word Complexity49%
investment, analyze, anticipate
Academic Markers3%
according to
Impersonal Style13%
837 personal pronouns found
Descriptive Style87%
monthly, carefully, actually
Description
The pharmaceutical space is characterized by extreme uncertainty. You never know what drugs are going to pan out. The lead time for development is extremely long. Market size is inherently unknowable. And the regulatory and pricing climate is constantly changing. So, how does a company decide where to invest its cash? On this episode, we speak with Moderna's chief financial officer, Jamey Mock, about how he views the problem. He explains the process by which the vaccine maker chooses which bets to make, how changing fortunes within the stock market affect corporate decision-making and the role of the government in accelerating progress and de-risking investment. See omnystudio.com/listener for privacy information.